BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2023 5:48:01 AM | Browse: 403 | Download: 1172
 |
Received |
|
2022-09-18 09:46 |
|
Peer-Review Started |
|
2022-09-18 09:48 |
|
First Decision by Editorial Office Director |
|
2022-10-20 06:15 |
|
Return for Revision |
|
2022-10-20 07:36 |
|
Revised |
|
2022-11-04 12:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-12-14 04:07 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-12-14 17:42 |
|
Articles in Press |
|
2022-12-14 17:42 |
|
Edit the Manuscript by Language Editor |
|
2022-12-02 00:45 |
|
Typeset the Manuscript |
|
2022-12-19 06:54 |
|
Publish the Manuscript Online |
|
2023-01-18 05:48 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Fan Li, Wen-Bing Zhang and Yu-Ye Gao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yi-Fan Li, MD, Chief Doctor, Surgeon, Department of General Surgery, Shanxi Cancer Hospital, No. 3 Xinghualing District，Staff New Village, Taiyuan 030013, Shanxi Province, China. lyf8028@126.com |
| Key Words |
Gastric cancer; Propensity score matching; Chemotherapy cycles; Overall survival; Progression-free survival; Recurrence |
| Core Tip |
This retrospective study determined the survival benefit of excess chemotherapy cycles for gastric cancer after D2 gastrectomy. No difference in progression-free survival and overall survival was observed between patients receiving ≥ 9 or < 9 cycles of chemotherapy. Stage III gastric cancer patients receiving ≥ 9 cycles of chemotherapy had significantly lower overall recurrence, local-regional metastasis, and distant metastasis. The Cox proportional risk regression model was used in the exploration and analysis that intestinal type, proximal gastrectomy, and ≥ 6 cm maximum tumor diameter had a higher risk of total mortality in the < 9 cycles of chemotherapy group. |
| Publish Date |
2023-01-18 05:48 |
| Citation |
Li YF, Zhang WB, Gao YY. Prognostic effects of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy. World J Gastrointest Surg 2023; 15(1): 32-48 |
| URL |
https://www.wjgnet.com/1948-9366/full/v15/i1/32.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i1.32 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
